Alaunos Therapeutics | Le Coût Des Ventes



Cost Of Sales Changement Date
Adcock Ingram Holdings ZAR 3.18B 115.21M 2024-12
Alaunos Therapeutics 0 18K 2024-09
Amgen USD 3.01B 406M 2025-06
AstraZeneca USD 2.47B 232M 2025-06
Baxter International USD 1.82B 55M 2025-06
Biogen USD 605M 24.3M 2025-06
Bioline Rx USD 34K 6.06M 2025-03
Bristol-Myers Squibb USD 3.37B 339M 2025-06
Celltrion KRW 399.04B 120.81B 2025-03
Corcept Therapeutics USD 3.43M 1.03M 2025-06
Cspc Pharmaceutical CNY 2.31B 299.94M 2025-03
Divis Laboratories Ltd 10.68B 870M 2025-06
Gilead Sciences USD 1.5B 39M 2025-06
GlaxoSmithKline GBP 2.16B 241M 2025-06
Incyte USD 78.77M 10.96M 2025-06
Ionis Pharmaceuticals USD 4.15M 3.15M 2025-06
J&J USD 7.6B 304M 2025-06
Kangmei Pharma CNY 1.06B 33.25M 2025-03
Knight Therapeutics CAD 47.25M 990K 2024-09
Laboratorios Farma EUR 152.05M 84.2M 2024-12
Malin Corporation EUR 15.4M 0 2020-12
Medical Developments International AUD 5.27M 2.92M 2024-12
Merck USD 2.82B 53M 2025-06
Novartis USD 3.32B 95M 2025-06
Organigram Holdings CAD 41.68M 69.31M 2024-12
Pfizer USD 4.99B 2.4B 2025-06
Pharma Mar EUR 2.78M 620K 2025-06
PTC Therapeutics USD 15.48M 2.62M 2025-06
Qiagen NV USD 199.25M 24.48M 2025-06
Regeneron Pharmaceuticals USD 530.2M 264.7M 2025-06
Roche Holding CHF 4.13B 393.5M 2024-12
Sartorius EUR 468.1M 16.1M 2025-06
Sino Biopharmaceutical CNY 2.49B 353.34M 2024-12
TG Therapeutics USD 18.94M 3.4M 2025-06
Tilray USD 149.73M 9.39M 2024-11
Zz Pientze Pharmaceu 1.73B 158.67M 2025-03


Alaunos Therapeutics Le Coût Des Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.